Featured Research

from universities, journals, and other organizations

Radiofrequency Treatment Better Than Ethanol Injection For Small Liver Tumors, Study Suggests

Date:
February 9, 2009
Source:
Wiley-Blackwell
Summary:
A new review of four randomized controlled trials that directly compared two different treatments for small inoperable liver tumors has found that radiofrequency ablation significantly improves patient survival compared to the standard therapy of percutaneous ethanol injection.

A new review of four randomized controlled trials that directly compared two different treatments for small inoperable liver tumors has found that radiofrequency ablation (RFA) significantly improves patient survival compared to the standard therapy of percutaneous ethanol injection (PEI). 

Related Articles


AASLD guidelines recommend PEI as a safe and highly effective treatment for small hepatocellular carcinomas and say it is the standard against which new therapies should be compared. RFA is one of a handful of alternative nonsurgical treatments for small liver tumors. It has a higher rate of adverse events and is not always usable depending on the location of the tumor, however, some studies have suggested it offers a greater survival benefit compared to PEI.

To determine the benefit of RFA compared to PEI, researchers led by Yun Ku Cho of Seoul conducted a systematic review and meta-analysis of randomized controlled trials that compared the two therapies. Using databases and manual searches, they identified all relevant, peer-reviewed studies published from 1978 through July 2008. Ultimately, only four studies, which included a total of 652 patients, contained enough information for a meta-analysis of three-year overall survival.

“Most randomized controlled trials identified definite survival benefit favoring RFA compared to PEI except the latest trial published in 2008,” the authors note. Their meta-analysis also detected a significant improvement in three-year survival for patients who’d undergone RFA.

“The additional survival benefit of RFA can be attributed to improved local tumor response of RFA, which in turn can be explained by the fact that more predictable tumor ablation was possible,” the authors suggest. While injected ethanol might be stopped by the liver’s fibrous septum or by satellite nodules, the heat from the radiofrequency electrode tip is distributed more homogenously.


Story Source:

The above story is based on materials provided by Wiley-Blackwell. Note: Materials may be edited for content and length.


Journal Reference:

  1. Cho, Yun Ku; Kim, Jae Kyun; Kim, Mi Young; Rhim, Hyunchul; Han, Joon Koo. Systemic Review of Randomized Trials for Hepatocellular Carcinoma Treated with Percutaneous Ablation Therapies. Hepatology, February 2009

Cite This Page:

Wiley-Blackwell. "Radiofrequency Treatment Better Than Ethanol Injection For Small Liver Tumors, Study Suggests." ScienceDaily. ScienceDaily, 9 February 2009. <www.sciencedaily.com/releases/2009/02/090203162334.htm>.
Wiley-Blackwell. (2009, February 9). Radiofrequency Treatment Better Than Ethanol Injection For Small Liver Tumors, Study Suggests. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2009/02/090203162334.htm
Wiley-Blackwell. "Radiofrequency Treatment Better Than Ethanol Injection For Small Liver Tumors, Study Suggests." ScienceDaily. www.sciencedaily.com/releases/2009/02/090203162334.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins